Acute pain management in the older adult is both challenging and rewarding. This review addresses the difficulty with assessment of pain in the older adult, variations in the pain experience of ...

"Suzetrigine’s non-opioid mechanism eliminates risks of misuse, addiction and respiratory depression, making it a safer alternative for acute pain management." In addition to acute pain ...

Pain management continues to be a priority animal welfare issue, particularly as updates to the beef cattle code of practice ...

Opioids like sufentanil and remifentanil during surgery may worsen post-surgery pain, highlighting the need for a review of ...

On January 30, 2025, the US FDA approved Journavx (suzetrigine) 50mg oral tablets to use in the treatment of moderate to severe acute pain, making it the first non-opioid analgesic of its class to ...

Novant Health Inc. has opened a clinic in Stokesdale focused on acute and chronic pain management. The facility is located at 7779 N.C. 68, Suite 2A, near Stokesdale Town Park.

On January 30, the U.S. Food and Drug Administration approved Journavx (suzetrigine) 50 milligram oral tablets, a first-in-class non-opioid ...

A recent clinical review published in the Journal of American Medical Association evaluated the comparative effectiveness and ...